"Immunoglobulin A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
| Descriptor ID |
D007070
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.026 D12.776.124.790.651.114.619.026 D12.776.377.715.548.114.619.026
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin A".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin A".
This graph shows the total number of publications written about "Immunoglobulin A" by people in this website by year, and whether "Immunoglobulin A" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 4 | 5 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 3 | 4 |
| 2017 | 17 | 31 | 48 |
| 2018 | 13 | 28 | 41 |
| 2019 | 3 | 14 | 17 |
| 2020 | 28 | 49 | 77 |
| 2021 | 12 | 52 | 64 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin A" by people in Profiles.
-
Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19. J Appl Lab Med. 2022 01 05; 7(1):382-386.
-
Global characterization of B cell receptor repertoire in COVID-19 patients by single-cell V(D)J sequencing. Brief Bioinform. 2021 11 05; 22(6).
-
Anti-SARS-CoV-2 IgA Response in Baseline Seronegative and Seropositive Recipients of BNT162b2 mRNA COVID-19 Vaccine. J Occup Environ Med. 2021 11 01; 63(11):e829.
-
Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays. Ann Lab Med. 2021 Nov 01; 41(6):577-587.
-
Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Mil Med Res. 2021 08 31; 8(1):47.
-
Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection. J Med Virol. 2022 01; 94(1):178-185.
-
Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity. Proc Natl Acad Sci U S A. 2021 08 24; 118(34).
-
Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain. Int J Environ Res Public Health. 2021 08 21; 18(16).
-
Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers. Breastfeed Med. 2021 12; 16(12):1004-1009.
-
Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19. EBioMedicine. 2021 Sep; 71:103519.